A proof-of-concept study utilising 2D NMR spectrometry for in situ characterisation and quantitation of key biomarkers and actives in tape stripped ex vivo human skin

Cameron Robertson; Nidhin Raj; Robert Lucas; Tomris Coban; Adam Le Gresley

doi:10.1016/j.talanta.2021.122980

A proof-of-concept study utilising 2D NMR spectrometry for in situ characterisation and quantitation of key biomarkers and actives in tape stripped ex vivo human skin

Cameron Robertson
, Nidhin Raj
, Robert Lucas
, Tomris Coban
, Adam Le Gresley

Research output: Contribution to journal › Article › peer-review

1 Downloads (Pure)

Original language	English
Article number	122980
Journal	Talanta
Volume	237
Early online date	20 Oct 2021
DOIs	https://doi.org/10.1016/j.talanta.2021.122980
Publication status	Published - 5 Jan 2022

Bibliographical note

Note: This work was supported by GlaxoSmithKline Consumer Healthcare.

Keywords

Pre-clinical and human biological sciences

Access to Document

10.1016/j.talanta.2021.122980

Robertson-C-50399-VoRFinal published version, 3.23 MBLicence: CC BY

https://doi.org/10.1016/j.talanta.2021.122980

Cite this

@article{8f4ce079016e4305a170039573c44a90,

title = "A proof-of-concept study utilising 2D NMR spectrometry for in situ characterisation and quantitation of key biomarkers and actives in tape stripped ex vivo human skin",

keywords = "Pre-clinical and human biological sciences",

author = "Cameron Robertson and Nidhin Raj and Robert Lucas and Tomris Coban and Gresley, \{Adam Le\}",

note = "Note: This work was supported by GlaxoSmithKline Consumer Healthcare.",

year = "2022",

month = jan,

day = "5",

doi = "10.1016/j.talanta.2021.122980",

language = "English",

volume = "237",

journal = "Talanta",

issn = "0039-9140",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - A proof-of-concept study utilising 2D NMR spectrometry for in situ characterisation and quantitation of key biomarkers and actives in tape stripped ex vivo human skin

AU - Robertson, Cameron

AU - Raj, Nidhin

AU - Lucas, Robert

AU - Coban, Tomris

AU - Gresley, Adam Le

N1 - Note: This work was supported by GlaxoSmithKline Consumer Healthcare.

PY - 2022/1/5

Y1 - 2022/1/5

KW - Pre-clinical and human biological sciences

U2 - 10.1016/j.talanta.2021.122980

DO - 10.1016/j.talanta.2021.122980

M3 - Article

SN - 0039-9140

VL - 237

JO - Talanta

JF - Talanta

M1 - 122980

ER -